This website has been developed by ALK and is intended for healthcare professionals only. Jext® is indicated in the emergency treatment of severe acute allergic reactions (anaphylaxis) to insect stings or bites, foods, drugs and other allergens as well as idiopathic or exercise induced anaphylaxis. Prescribing Information UK ROI

  • Home
  • Resources
    • Resources
    • Order Literature
    • Jext®app
  • FAQs
Contact Us
Expiry Alert Service
Order literature

There are a number of Jext® resources available for you to download or order online. To place an order for any of our free items, please use the form below. The purpose of this page is for HCPs to order Jext® support materials to give to patients. To order direct to patients, please signpost your patients to the relevant patient section on the Jext® website.

Please note, there are quantity restrictions on items.

"(Required)" indicates required fields

1Step 1
2Step 2
3Step 3

Adult Patient Brochure

Educate patients on anaphylaxis, how to administer Jext® and registering for the free expiry alert service.*

Kids Patient Brochure

Educate patients on anaphylaxis, how to administer Jext® and registering for the free expiry alert service.*

Patient ‘Lifeline’ Card

Educate patients on anaphylaxis and how to administer Jext®. Patients should carry this card with them at all times.

Jext® Trainer

The trainer contains no adrenaline or needle. Use to teach how to correctly administer Jext®.

Order Now

Prescriber Checklist

Fill in the Jext® Prescriber Checklist, to ensure your patient has everything they need to start using their Jext®.†

* To order more of this item, please contact your Jext® representative ; † Only one per healthcare professional can be ordered.

* Required field

Untitled
Untitled
Consent(Required)

Information entered on this website may be used by a third party for the purposes of fulfilling your request for information or materials. ALK-Abelló Ltd will not pass your details to other third parties. We will only send you product information and promotional information we think may be of interest. You are under no obligation to grant an interview to a company representative.

January 2025
IE-JXT-2400015

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (for the United Kingdom) or www.hpra.ie (for Republic of Ireland).

Adverse events should also be reported to ALK-Abelló Ltd. Email: drugsafetyuk@alk.net Phone: +44(0)118 903 7940

Terms of Use
This site provides additional patient information to ONLY those patients who are currently prescribed Jext®. Any information contained in this site should not be acted upon without first consulting your doctor. Jext® is a registered trademark of ALK-Abelló Ltd.

Click below for:

Jext 150mcg SPC
UK ROI
Jext 300mcg SPC
UK ROI
Patient Information Leaflet
UK ROI

ALK-Abelló Ltd, 1 Manor Park,
Manor Farm Road,
Reading, Berkshire,
RG2 0NA

Tel: +44(0)118 903 7940

Email: infouk@alk.net

© Copyright 2025 ALK-Abelló LtdContact usDisclaimerPrivacy NoticeExpiry Alert Cancellation

January 2025
IE-JXT-2400021